Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

EQS-Adhoc: Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.


EQS-Ad-hoc: Eckert Ziegler SE / Key word(s): Quarter Results/Preliminary Results
Eckert Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.

22-Apr-2024 / 14:49 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


1st Quarter 2024:

  • Sales of EUR 67.6 million (previous year: EUR 57.9 million)
  • EBIT before special items of EUR 15.0 million (previous year: EUR 10.7 million)
  • Net income for the year of EUR 8.5 million (previous year: EUR 4.7 million)

Forecast FY 2024:

  • Sales of just under 265 million EUR (confirmed)
  • EBIT before special items of around EUR 50 million (confirmed)

Berlin, 22 April 2024. According to preliminary calculations, Eckert Ziegler SE (ISIN DE0005659700, TecDAX) achieved sales of EUR 67.6 million in the first quarter of 2024 (previous year: EUR 57.9 million). The key figure EBIT before special items introduced as part of the 2024 forecast amounted to EUR 15.0 million in the first quarter of 2024 (previous year: EUR 10.7 million). Net income, which is only reported here on a comparative basis, increased to EUR 8.5 million (previous year: EUR 4.7 million).

The forecast for the 2024 financial year published on March 22, 2024 remains unchanged. The Executive Board continues to expect sales of just under EUR 265 million and EBIT before special items of around EUR 50 million.

The complete figures for the first quarter of 2024 will be published on May 14, 2024.

Contact:
Eckert Ziegler SE
Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com 



End of Inside Information

22-Apr-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Eckert Ziegler SE
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-0
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX, TecDax,
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1886109

 
End of Announcement EQS News Service

1886109  22-Apr-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1886109&application_name=news&site_id=sharewise~~~202ee175-2c72-4a50-a0f7-89cd8fcfa533

Eckert & Ziegler Strahlen- und Medizintechnik AG Aktie

38,54 €
-0,16 %
Ein leichter Kursrückgang bei Eckert & Ziegler Strahlen- und Medizintechnik AG heute, um -0,16 %.
Eine klare Neigung zu Buy-Einschätzungen bei Eckert & Ziegler Strahlen- und Medizintechnik AG, ohne Sell-Einschätzungen.
Das von der Community festgelegte Kursziel für Eckert & Ziegler Strahlen- und Medizintechnik AG von 95 € würde den aktuellen Kurs von 38.54 € mehr als verdoppeln.
Like: 0
Teilen
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Rechtlicher Hinweis

Kommentare